A Japanese nationwide survey on the cryopreservation of embryos, oocytes and ovarian tissue for cancer patients

Yuko Sanada, Miyuki Harada, Chisato Kunitomi, Mayuko Kanatani, Gentaro Izumi, Tetsuya Hirata, Tomoyuki Fujii, Nao Suzuki, Ken ichirou Morishige, Daisuke Aoki, Minoru Irahara, Koichiro Tsugawa, Mitsune Tanimoto, Hiroyuki Nishiyama, Hajime Hosoi, Kazuhiko Sugiyama, Akira Kawai, Yutaka Osuga

Research output: Contribution to journalArticle

Abstract

Aim: The survival rates of cancer patients have greatly improved owing to the advances in oncology. The preservation of fertility in cancer patients is an important task. To determine the reality of cryopreservation of embryos, oocytes and ovarian tissue in cancer patients, large-scale survey analysis was performed in Japan. Methods: We sent 613 Japan Society of Obstetrics and Gynecology-certified assisted reproductive technology institutions a questionnaire about their experience of performing cryopreservation for cancer patients between January 2011 and December 2015. Subsequently, the institutions that conducted cryopreservation for cancer patients were sent a second questionnaire. Results: We received replies from 481 (78.5%) institutions. Among them, 126 (26.2%) conducted cryopreservation for cancer patients. These 126 institutions were sent a second questionnaire. Of these, 108 (85.7%) institutions responded. At the 108 institutions, 1085 embryo or oocyte cryopreservation procedures and 122 ovarian tissue cryopreservation procedures were conducted for cancer patients. Cryopreservation was mainly performed for breast cancer patients (~70%), followed by patients with hematological malignancy. A total of 361 and 19 embryo transfer cycles were performed for patients whose embryos and oocytes were cryopreserved, respectively, and 42 and seven institutions reported pregnancy outcomes after embryo transfer in patients that underwent embryo and oocyte cryopreservation, respectively. However, pregnancy was not observed in the seven cases that underwent ovarian tissue transfer. Conclusion: Indications, age limits and ovarian stimulation protocols for cryopreservation widely varied between the institutions. A national registration system for oncofertility must be established to evaluate the safety and efficacy of the current system.

Original languageEnglish
Pages (from-to)2021-2028
Number of pages8
JournalJournal of Obstetrics and Gynaecology Research
Volume45
Issue number10
DOIs
Publication statusPublished - 2019 Oct 1

Fingerprint

Cryopreservation
Ovarian Neoplasms
Oocytes
Embryonic Structures
Neoplasms
Embryo Transfer
Japan
Surveys and Questionnaires
Fertility Preservation
Assisted Reproductive Techniques
Ovulation Induction
Hematologic Neoplasms
Pregnancy Outcome
Gynecology
Obstetrics
Survival Rate
Breast Neoplasms
Safety
Pregnancy

Keywords

  • assisted reproductive technology
  • breast cancer
  • controlled ovarian stimulation
  • cryopreservation
  • oncofertility

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

A Japanese nationwide survey on the cryopreservation of embryos, oocytes and ovarian tissue for cancer patients. / Sanada, Yuko; Harada, Miyuki; Kunitomi, Chisato; Kanatani, Mayuko; Izumi, Gentaro; Hirata, Tetsuya; Fujii, Tomoyuki; Suzuki, Nao; Morishige, Ken ichirou; Aoki, Daisuke; Irahara, Minoru; Tsugawa, Koichiro; Tanimoto, Mitsune; Nishiyama, Hiroyuki; Hosoi, Hajime; Sugiyama, Kazuhiko; Kawai, Akira; Osuga, Yutaka.

In: Journal of Obstetrics and Gynaecology Research, Vol. 45, No. 10, 01.10.2019, p. 2021-2028.

Research output: Contribution to journalArticle

Sanada, Y, Harada, M, Kunitomi, C, Kanatani, M, Izumi, G, Hirata, T, Fujii, T, Suzuki, N, Morishige, KI, Aoki, D, Irahara, M, Tsugawa, K, Tanimoto, M, Nishiyama, H, Hosoi, H, Sugiyama, K, Kawai, A & Osuga, Y 2019, 'A Japanese nationwide survey on the cryopreservation of embryos, oocytes and ovarian tissue for cancer patients', Journal of Obstetrics and Gynaecology Research, vol. 45, no. 10, pp. 2021-2028. https://doi.org/10.1111/jog.14073
Sanada, Yuko ; Harada, Miyuki ; Kunitomi, Chisato ; Kanatani, Mayuko ; Izumi, Gentaro ; Hirata, Tetsuya ; Fujii, Tomoyuki ; Suzuki, Nao ; Morishige, Ken ichirou ; Aoki, Daisuke ; Irahara, Minoru ; Tsugawa, Koichiro ; Tanimoto, Mitsune ; Nishiyama, Hiroyuki ; Hosoi, Hajime ; Sugiyama, Kazuhiko ; Kawai, Akira ; Osuga, Yutaka. / A Japanese nationwide survey on the cryopreservation of embryos, oocytes and ovarian tissue for cancer patients. In: Journal of Obstetrics and Gynaecology Research. 2019 ; Vol. 45, No. 10. pp. 2021-2028.
@article{6d35afbfa07f424faa5219ba4a3e91da,
title = "A Japanese nationwide survey on the cryopreservation of embryos, oocytes and ovarian tissue for cancer patients",
abstract = "Aim: The survival rates of cancer patients have greatly improved owing to the advances in oncology. The preservation of fertility in cancer patients is an important task. To determine the reality of cryopreservation of embryos, oocytes and ovarian tissue in cancer patients, large-scale survey analysis was performed in Japan. Methods: We sent 613 Japan Society of Obstetrics and Gynecology-certified assisted reproductive technology institutions a questionnaire about their experience of performing cryopreservation for cancer patients between January 2011 and December 2015. Subsequently, the institutions that conducted cryopreservation for cancer patients were sent a second questionnaire. Results: We received replies from 481 (78.5{\%}) institutions. Among them, 126 (26.2{\%}) conducted cryopreservation for cancer patients. These 126 institutions were sent a second questionnaire. Of these, 108 (85.7{\%}) institutions responded. At the 108 institutions, 1085 embryo or oocyte cryopreservation procedures and 122 ovarian tissue cryopreservation procedures were conducted for cancer patients. Cryopreservation was mainly performed for breast cancer patients (~70{\%}), followed by patients with hematological malignancy. A total of 361 and 19 embryo transfer cycles were performed for patients whose embryos and oocytes were cryopreserved, respectively, and 42 and seven institutions reported pregnancy outcomes after embryo transfer in patients that underwent embryo and oocyte cryopreservation, respectively. However, pregnancy was not observed in the seven cases that underwent ovarian tissue transfer. Conclusion: Indications, age limits and ovarian stimulation protocols for cryopreservation widely varied between the institutions. A national registration system for oncofertility must be established to evaluate the safety and efficacy of the current system.",
keywords = "assisted reproductive technology, breast cancer, controlled ovarian stimulation, cryopreservation, oncofertility",
author = "Yuko Sanada and Miyuki Harada and Chisato Kunitomi and Mayuko Kanatani and Gentaro Izumi and Tetsuya Hirata and Tomoyuki Fujii and Nao Suzuki and Morishige, {Ken ichirou} and Daisuke Aoki and Minoru Irahara and Koichiro Tsugawa and Mitsune Tanimoto and Hiroyuki Nishiyama and Hajime Hosoi and Kazuhiko Sugiyama and Akira Kawai and Yutaka Osuga",
year = "2019",
month = "10",
day = "1",
doi = "10.1111/jog.14073",
language = "English",
volume = "45",
pages = "2021--2028",
journal = "Asia-Oceania Journal of Obstetrics and Gynaecology",
issn = "1341-8076",
publisher = "Blackwell Publishing Asia",
number = "10",

}

TY - JOUR

T1 - A Japanese nationwide survey on the cryopreservation of embryos, oocytes and ovarian tissue for cancer patients

AU - Sanada, Yuko

AU - Harada, Miyuki

AU - Kunitomi, Chisato

AU - Kanatani, Mayuko

AU - Izumi, Gentaro

AU - Hirata, Tetsuya

AU - Fujii, Tomoyuki

AU - Suzuki, Nao

AU - Morishige, Ken ichirou

AU - Aoki, Daisuke

AU - Irahara, Minoru

AU - Tsugawa, Koichiro

AU - Tanimoto, Mitsune

AU - Nishiyama, Hiroyuki

AU - Hosoi, Hajime

AU - Sugiyama, Kazuhiko

AU - Kawai, Akira

AU - Osuga, Yutaka

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Aim: The survival rates of cancer patients have greatly improved owing to the advances in oncology. The preservation of fertility in cancer patients is an important task. To determine the reality of cryopreservation of embryos, oocytes and ovarian tissue in cancer patients, large-scale survey analysis was performed in Japan. Methods: We sent 613 Japan Society of Obstetrics and Gynecology-certified assisted reproductive technology institutions a questionnaire about their experience of performing cryopreservation for cancer patients between January 2011 and December 2015. Subsequently, the institutions that conducted cryopreservation for cancer patients were sent a second questionnaire. Results: We received replies from 481 (78.5%) institutions. Among them, 126 (26.2%) conducted cryopreservation for cancer patients. These 126 institutions were sent a second questionnaire. Of these, 108 (85.7%) institutions responded. At the 108 institutions, 1085 embryo or oocyte cryopreservation procedures and 122 ovarian tissue cryopreservation procedures were conducted for cancer patients. Cryopreservation was mainly performed for breast cancer patients (~70%), followed by patients with hematological malignancy. A total of 361 and 19 embryo transfer cycles were performed for patients whose embryos and oocytes were cryopreserved, respectively, and 42 and seven institutions reported pregnancy outcomes after embryo transfer in patients that underwent embryo and oocyte cryopreservation, respectively. However, pregnancy was not observed in the seven cases that underwent ovarian tissue transfer. Conclusion: Indications, age limits and ovarian stimulation protocols for cryopreservation widely varied between the institutions. A national registration system for oncofertility must be established to evaluate the safety and efficacy of the current system.

AB - Aim: The survival rates of cancer patients have greatly improved owing to the advances in oncology. The preservation of fertility in cancer patients is an important task. To determine the reality of cryopreservation of embryos, oocytes and ovarian tissue in cancer patients, large-scale survey analysis was performed in Japan. Methods: We sent 613 Japan Society of Obstetrics and Gynecology-certified assisted reproductive technology institutions a questionnaire about their experience of performing cryopreservation for cancer patients between January 2011 and December 2015. Subsequently, the institutions that conducted cryopreservation for cancer patients were sent a second questionnaire. Results: We received replies from 481 (78.5%) institutions. Among them, 126 (26.2%) conducted cryopreservation for cancer patients. These 126 institutions were sent a second questionnaire. Of these, 108 (85.7%) institutions responded. At the 108 institutions, 1085 embryo or oocyte cryopreservation procedures and 122 ovarian tissue cryopreservation procedures were conducted for cancer patients. Cryopreservation was mainly performed for breast cancer patients (~70%), followed by patients with hematological malignancy. A total of 361 and 19 embryo transfer cycles were performed for patients whose embryos and oocytes were cryopreserved, respectively, and 42 and seven institutions reported pregnancy outcomes after embryo transfer in patients that underwent embryo and oocyte cryopreservation, respectively. However, pregnancy was not observed in the seven cases that underwent ovarian tissue transfer. Conclusion: Indications, age limits and ovarian stimulation protocols for cryopreservation widely varied between the institutions. A national registration system for oncofertility must be established to evaluate the safety and efficacy of the current system.

KW - assisted reproductive technology

KW - breast cancer

KW - controlled ovarian stimulation

KW - cryopreservation

KW - oncofertility

UR - http://www.scopus.com/inward/record.url?scp=85072848513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072848513&partnerID=8YFLogxK

U2 - 10.1111/jog.14073

DO - 10.1111/jog.14073

M3 - Article

C2 - 31364239

AN - SCOPUS:85072848513

VL - 45

SP - 2021

EP - 2028

JO - Asia-Oceania Journal of Obstetrics and Gynaecology

JF - Asia-Oceania Journal of Obstetrics and Gynaecology

SN - 1341-8076

IS - 10

ER -